Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: (("biological theory") OR ("biological therapy"))
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
author_facet:"Canadian Agency for Drugs and Technologies in Health"
dewey-ones:"330 - Economics"
Search alternatives
:
"biological theory" »
"ecological theory"
,
"sociological theory"
,
"topological theory"
Showing
1
-
7
of
7
Search:
'(("biological theory") OR ("biological therapy"))'
,
query time: 0.28s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
1
CADTH Canadian Drug Expert Committee recommendation: Risankizumab (Skyrizi -- Abbvie) : indication : adult patients with moderate to severe plaque psoriasis
Published 2019
CADTH
“
...
biologic
therapy
reimbursed for the treatment of moderate to severe plaque psoriasis...
”
Read Now
2
Early biologic treatment versus conventional treatment for the management of Crohn's disease : a review of comparative clinical effectiveness and cost-effectiveness
by
Thompson, Wade
,
Argáez, Charlene
Published 2019
CADTH
“
... the clinical and cost-effectiveness of early
biologic
therapy
compared to conventional treatment for Crohn...
”
Read Now
3
Early biologic treatment versus conventional treatment for the management of Crohn's disease : a review of comparative clinical effectiveness and cost-effectiveness
by
Thompson, Wade
,
Argáez, Charlene
Published 2019
CADTH
“
... the clinical and cost-effectiveness of early
biologic
therapy
compared to conventional treatment for Crohn...
”
Read Now
4
Pharmacoeconomic review report: Risankizumab (Skyrizi) (AbbVie)
Published 2019
Canadian Agency for Drugs and Technologies in Health
“
... analysis based on a Markov state-transition model comparing risankizumab with the following
biologic
...
”
Read Now
5
Pharmacoeconomic review report: Risankizumab (Skyrizi) (AbbVie)
Published 2019
Canadian Agency for Drugs and Technologies in Health
“
... analysis based on a Markov state-transition model comparing risankizumab with the following
biologic
...
”
Read Now
6
Pharmacoeconomic review report: Certolizumab pegol (Cimzia) : (UCB Canada Inc.) : indication : for the treatment of adult patients with moderate-to-severe plaque psoriasis who are...
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
... model comparing certolizumab pegol with best supportive care (BSC) and the following
biologic
therapies
...
”
Read Now
7
Pharmacoeconomic review report: Certolizumab pegol (Cimzia) : (UCB Canada Inc.) : indication : for the treatment of adult patients with moderate-to-severe plaque psoriasis who are...
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
... model comparing certolizumab pegol with best supportive care (BSC) and the following
biologic
therapies
...
”
Back
Narrow Search
Remove Filters
Clear Filter
Author: Canadian Agency for Drugs and Technologies in Health
Clear Filter
Classification: 330 - Economics
Year of Publication
From:
To:
Classification
330 - Economics
610 - Medicine & health
3
Language
English
7
Collection
National Center for Biotechnology Information
7
Author
Canadian Agency for Drugs and Technologies in Health
Argáez, Charlene
2
Canadian Agency for Drugs and Technologies in Health Rapid Response Service
2
Thompson, Wade
2
CADTH Canadian Drug Expert Committee
1
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?filter%5B%5D=author_facet%3A%22Canadian+Agency+for+Drugs+and+Technologies+in+Health%22&filter%5B%5D=dewey-ones%3A%22330+-+Economics%22&lookfor=%28%28%22biological+theory%22%29+OR+%28%22biological+therapy%22%29%29&type=AllFields
Send by Email
×
Loading...